Enanta Pharma (ENTA)
11.52
+0.08 (0.70%)
Upcoming Events
Latest Headlines
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 28, 2026 7:00 AM - BizWire
Form S-8 ENANTA PHARMACEUTICALS
May 13, 2026 7:26 AM - SEC Filing
Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31
May 13, 2026 7:01 AM - SEC Filing
Form 8-K ENANTA PHARMACEUTICALS For: May 11
May 11, 2026 4:06 PM - SEC Filing
Enanta Pharma (ENTA) Tops Q2 EPS by 12c
May 11, 2026 4:01 PM - StreetInsider
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
May 11, 2026 4:01 PM - BizWire
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus and STAT6 Inhibitor Programs at the American Thoracic Society International Conference 2026
May 4, 2026 7:00 AM - BizWire
Enanta begins phase 1 trial of oral KIT inhibitor for urticaria
April 13, 2026 7:00 AM - StreetInsider
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
April 13, 2026 7:00 AM - BizWire
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026
April 7, 2026 7:24 AM - BizWire
Jefferies stays Buy on Enanta Pharmaceuticals (ENTA) as co announces oral arguments for PFE patent case
March 31, 2026 4:52 PM - StreetInsider
Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)
March 30, 2026 7:00 AM - BizWire
Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: VANGUARD GROUP INC
March 26, 2026 6:07 PM - SEC Filing
Form 8-K ENANTA PHARMACEUTICALS For: Mar 20
March 26, 2026 8:00 AM - SEC Filing
Rodman & Renshaw Starts Enanta Pharmaceuticals (ENTA) at Buy
March 26, 2026 6:32 AM - StreetInsider
Full Article List
